Ausgabe 2/2016
Inhalt (11 Artikel)
Combination Therapies for Melanoma: A New Standard of Care?
Keiran S. M. Smalley, Zeynep Eroglu, Vernon K. Sondak
IL-17 Blockade in Psoriasis: Friend or Foe in Cardiovascular Risk?
Tiago Torres, Inês Raposo, Manuela Selores
Coffee Consumption and Melanoma: A Systematic Review and Meta-Analysis of Observational Studies
Yik Weng Yew, Yi Chun Lai, Robert A. Schwartz
Ultraviolet B Phototherapy for Psoriasis: Review of Practical Guidelines
Dhwani Mehta, Henry W. Lim
Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment
Emily Z. Hejazi, Victoria P. Werth
Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects
Yun Xue, Jeffrey M. Cohen, Natalie A. Wright, Joseph F. Merola
Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit
Christine Blome, Marc A. Radtke, Leah Eissing, Matthias Augustin
Primary Burning Mouth Syndrome: A Questionnaire Study of Neuropathic and Psychological Components
Morgane Sevrain, Emilie Brenaut, Guy Le Toux, Laurent Misery
Afamelanotide: A Review in Erythropoietic Protoporphyria
Esther S. Kim, Karly P. Garnock-Jones
Comment on: “Association between Atopic Dermatitis and Autism Spectrum Disorders: A Systematic Review”
Keith Fluegge
Reply to Fluegge: Association Between Atopic Dermatitis and Autism Spectrum Disorders: A Systematic Review
Lucia Billeci, Alessandro Tonacci, Gennaro Tartarisco, Liliana Ruta, Giovanni Pioggia, Sebastiano Gangemi